In an independent study presented during the North American Spine Society (NASS) Annual Meeting in October 2012, GE Healthcare’s OEC Elite 9900 mobile C-arm was rated the best in image quality and dose management.

Aggredyne Inc., has received ISO 13485 certification for its quality control program related to the manufacture of the AggreGuide family of platelet function analyzers.


Cardiologists are increasingly accessing coronary arteries by way of the wrist rather than the groin to insert life-saving stents into patients with blocked arteries, according to the first broad report of the American College of Cardiology’s clinical data registries published online in the Journal of the American College of Cardiology.

OrbusNeich Medical Inc. and Boston Scientific Corp. have settled all stent-related litigation between the companies.

TeraRecon announced positive ratings in the recently released KLAS 2013 Advanced Visualization performance report entitled “Advanced Visualization 2013: How Advanced Is It?” TeraRecon’s general performance ratings were particularly noteworthy, in that the company received the top scores for the following general indicators:

Todd Dunlap, 62, arrived at Ronald Reagan UCLA Medical Center's emergency room on Aug. 8 suffering from shortness of breath, fatigue and extreme cold. When a computed (CT) scan revealed a 24-inch clot stretching from his legs into his heart, doctors feared the mass could break loose and lodge in his lungs, blocking oxygen and killing him instantly.

The Mount Sinai Medical Center is participating in the nationwide Absorb III clinical trial testing the performance and potential clinical benefits of a fully dissolvable and temporary drug eluting stent to open heart artery blockages. The randomized trial aims to compare the efficiency and safety of Absorb Bioresorbable Vascular Scaffolds (Absorb BVS) in coronary artery disease patients and compare it to the current standard of care — drug eluting metal stents.

Corindus Vascular Robotics announced the PRECISION Registry, an ongoing study aimed at collecting data on the patterns of use, safety and effectiveness in the delivery and manipulation of percutaneous coronary intervention (PCI) devices. Giora Weisz, associate professor of Medicine at Columbia University Medical Center, will lead the study.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now